Hamed Sajjadi, MD
Otolaryngology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 7 carriers
- Office
- 1
Offices
1 location · San Jose Ear and Sinus Medical Center Inc · 2 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
28 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sajjadi’s office at (408) 358-8507 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G48506 · Current
Licensed to practise in California · since 1982 · expires 2028-05-31 · Creighton University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Forest Surgery Center LPAmbulatory Surgery Center · San Jose, CAOwner · accredited by JCAccreditation Renewed1 inspection, 1 with deficiencies · last 2012-09-18: Requirements Met
- Silicon Valley Surgery Center, LPAmbulatory Surgery Center · Campbell, CA1.05% owner since 2013 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-09-16
- Silicon Valley Surgery Center, LP - BascomAmbulatory Surgery Center · Campbell, CA1.05% owner since 2013 · accredited by AAAHCAccreditation RenewedNo inspections published
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$165,409
Medicare paid this office $165,409 for 664 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 315 | $48,890 | $112 |
| New patient visit (45+ min) | 193 | $28,223 | $146 |
| Comprehensive hearing and speech recognition test | 416 | $14,126 | $32 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 386 | $11,725 | $29 |
| Diagnostic exam of nasal passages using an endoscope | 44 | $8,147 | $173 |
See all 17 services
| Return visit (30+ min) | 315 | $48,890 | $112 |
| New patient visit (45+ min) | 193 | $28,223 | $146 |
| Comprehensive hearing and speech recognition test | 416 | $14,126 | $32 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 386 | $11,725 | $29 |
| Diagnostic exam of nasal passages using an endoscope | 44 | $8,147 | $173 |
| Test for eardrum and muscle function | 371 | $7,711 | $20 |
| Long return visit (40+ min) | 34 | $6,269 | $157 |
| New patient visit (60+ min) | 23 | $4,408 | $192 |
| Diagnostic exam of voice box using a flexible endoscope | 26 | $3,472 | $120 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 15 | $3,274 | $205 |
| Short return visit (20+ min) | 32 | $2,817 | $83 |
| Exam of ear using a microscope | 92 | $2,789 | $29 |
| Removal of impacted ear wax | 49 | $1,845 | $38 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 75 | $1,180 | $15 |
| Test for abnormal eye movement using 3 positions with recording | 41 | $1,151 | $27 |
| Analysis and reprogramming of inner ear implant (7 years or older) | 12 | $1,134 | $71 |
| Test to assess middle ear function | 26 | $408 | $15 |
Who their Medicare patients are
664 Original Medicare patients in 2024. Average age 78 · Women 58% · Also on Medicaid 11% · Health risk score 1.08. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 74% · Coronary heart disease 34% · Diabetes 29% · Atrial fibrillation 20% · Cancer 18% · Chronic kidney disease 16% · Heart failure 13% · Depression 11% · Stroke 9% · COPD 8% · Dementia 6%.
The office billed $689,664, Medicare allowed $224,833 and paid $165,409; for 2,469 services of 48 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 664 | 2,469 | 78 | 1.08 | $689,664 | $165,409 |
| 2023 | 702 | 2,934 | 78 | 1.11 | $809,531 | $201,539 |
| 2022 | 723 | 2,717 | 77 | 1.11 | $766,787 | $192,273 |
| 2021 | 614 | 2,097 | 77 | 1.08 | $604,729 | $145,747 |
| 2020 | 505 | 1,138 | 76 | 1.12 | $460,577 | $95,666 |
| 2019 | 600 | 1,439 | 76 | 1.13 | $662,936 | $127,054 |
| 2018 | 585 | 1,252 | 76 | 1.13 | $576,292 | $112,554 |
| 2017 | 549 | 1,325 | 75 | 1.13 | $577,031 | $118,416 |
| 2016 | 543 | 1,514 | 75 | 1.09 | $577,276 | $135,736 |
| 2015 | 555 | 1,620 | 75 | 1.11 | $534,624 | $136,915 |
| 2014 | 539 | 1,729 | 74 | 1.04 | $609,297 | $148,924 |
| 2013 | 416 | 1,247 | 75 | 1.02 | $493,637 | $116,594 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Return visit (30+ min) | 341 | $57,316 | $112 |
| New patient visit (45+ min) | 197 | $28,643 | $145 |
| Comprehensive hearing and speech recognition test | 518 | $19,073 | $33 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 420 | $13,259 | $29 |
| Test for eardrum and muscle function | 493 | $10,998 | $20 |
| New patient visit (60+ min) | 37 | $6,957 | $188 |
| Long return visit (40+ min) | 35 | $5,961 | $157 |
| Diagnostic exam of nasal passages using an endoscope | 25 | $5,360 | $191 |
| Exam of ear using a microscope | 124 | $4,386 | $29 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 16 | $4,199 | $247 |
| Diagnostic exam of voice box using a flexible endoscope | 19 | $2,489 | $131 |
| Vemp testing of upper and lower branches of inner ear nerve with interpretation and report | 19 | $2,478 | $130 |
| Evaluation of hearing function related to surgically implanted hearing device, first hour | 18 | $2,238 | $75 |
| Test to assess electrical potentials generated in the inner ear as a result of sound stimulation | 17 | $1,953 | $115 |
| Removal of impacted ear wax | 39 | $1,886 | $45 |
| Evaluation and testing for balance with recording | 17 | $1,829 | $108 |
| Test for abnormal eye movement using 3 positions with recording | 53 | $1,551 | $28 |
| Short return visit (20+ min) | 15 | $1,412 | $78 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 12 | $522 | $43 |
| Test to assess middle ear function | 16 | $246 | $15 |
2022: 20 services
| Return visit (30+ min) | 333 | $54,388 | $112 |
| New patient visit (45+ min) | 213 | $29,275 | $137 |
| Comprehensive hearing and speech recognition test | 555 | $19,646 | $32 |
| Test for eardrum and muscle function | 478 | $10,364 | $20 |
| New patient visit (60+ min) | 43 | $8,237 | $192 |
| Diagnostic exam of nasal passages using an endoscope | 32 | $7,048 | $196 |
| Long return visit (40+ min) | 25 | $4,971 | $166 |
| Diagnostic exam of voice box using a flexible endoscope | 23 | $3,174 | $132 |
| Analysis and reprogramming of inner ear implant (7 years or older) | 12 | $3,024 | $84 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 11 | $2,824 | $235 |
| Removal of impacted ear wax | 65 | $2,821 | $41 |
| Exam of ear using a microscope | 91 | $2,739 | $26 |
| Evaluation of hearing function related to surgically implanted hearing device, first hour | 17 | $2,489 | $83 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 78 | $2,462 | $32 |
| Short return visit (20+ min) | 24 | $1,809 | $75 |
| Placement of ear probe for computerized measurement of sound with interpretation and report | 85 | $1,754 | $21 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 34 | $1,577 | $46 |
| Test to assess middle ear function | 103 | $1,547 | $15 |
| New patient visit (30+ min) | 14 | $1,333 | $95 |
| Test for abnormal eye movement using 3 positions with recording | 45 | $1,296 | $28 |
2021: 16 services
| Return visit (30+ min) | 238 | $36,050 | $119 |
| New patient visit (45+ min) | 193 | $29,188 | $151 |
| Short return visit (20+ min) | 97 | $9,617 | $84 |
| Comprehensive hearing and speech recognition test | 246 | $9,490 | $37 |
| Diagnostic exam of nasal passages using an endoscope | 36 | $7,498 | $203 |
| New patient visit (60+ min) | 33 | $6,465 | $196 |
| Long return visit (40+ min) | 25 | $4,708 | $174 |
| Exam of ear using a microscope | 142 | $4,568 | $28 |
| Test for eardrum and muscle function | 152 | $3,318 | $22 |
| Telephone medical discussion with physician, 11-20 minutes | 33 | $2,875 | $85 |
| New patient visit (30+ min) | 28 | $2,549 | $91 |
| Test for abnormal eye movement using 3 positions with recording | 62 | $1,762 | $28 |
| Test to assess middle ear function | 98 | $1,657 | $17 |
| Placement of ear probe for computerized measurement of sound with interpretation and report | 47 | $1,027 | $22 |
| Removal of impacted ear wax | 19 | $847 | $45 |
| Repositioning exercises of head for treatment of dizziness, each day | 13 | $516 | $40 |
2020: 11 services
| Short return visit (20+ min) | 266 | $22,851 | $66 |
| Return visit (30+ min) | 116 | $14,702 | $107 |
| New patient visit (30+ min) | 99 | $9,194 | $93 |
| New patient visit (45+ min) | 60 | $9,129 | $152 |
| New patient visit (60+ min) | 39 | $7,529 | $193 |
| Diagnostic exam of nasal passages using an endoscope | 28 | $6,348 | $198 |
| Exam of ear using a microscope | 142 | $4,429 | $28 |
| Telephone medical discussion with physician, 21-30 minutes | 30 | $3,707 | $103 |
| Long return visit (40+ min) | 25 | $3,444 | $138 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,471 | $74 |
| Test for abnormal eye movement using 3 positions with recording | 25 | $613 | $23 |
2019: 12 services
| Short return visit (20+ min) | 373 | $33,168 | $66 |
| Return visit (30+ min) | 131 | $14,787 | $92 |
| New patient visit (45+ min) | 68 | $10,223 | $150 |
| New patient visit (30+ min) | 104 | $9,914 | $95 |
| Diagnostic exam of nasal passages using an endoscope | 32 | $8,266 | $197 |
| Exam of ear using a microscope | 171 | $5,228 | $26 |
| Diagnostic exam of voice box using a flexible endoscope | 45 | $4,997 | $109 |
| New patient visit (60+ min) | 21 | $3,939 | $188 |
| Long return visit (40+ min) | 24 | $3,436 | $137 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 13 | $2,685 | $207 |
| Test for abnormal eye movement using 3 positions with recording | 45 | $1,174 | $24 |
| Removal of impacted ear wax | 32 | $1,062 | $33 |
2018: 11 services
| Short return visit (20+ min) | 365 | $28,724 | $62 |
| Return visit (30+ min) | 143 | $15,836 | $95 |
| New patient visit (45+ min) | 65 | $9,492 | $146 |
| New patient visit (30+ min) | 98 | $9,046 | $92 |
| Diagnostic exam of nasal passages using an endoscope | 33 | $8,650 | $201 |
| Diagnostic exam of voice box using a flexible endoscope | 54 | $5,445 | $97 |
| Exam of ear using a microscope | 161 | $4,797 | $25 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 16 | $4,132 | $207 |
| New patient visit (60+ min) | 12 | $2,265 | $189 |
| Long return visit (40+ min) | 13 | $2,047 | $136 |
| Test for abnormal eye movement using 3 positions with recording | 48 | $1,252 | $24 |
2017: 14 services
| Short return visit (20+ min) | 358 | $31,355 | $64 |
| Return visit (30+ min) | 123 | $13,201 | $95 |
| New patient visit (45+ min) | 76 | $10,862 | $143 |
| Diagnostic exam of nasal passages using an endoscope | 36 | $9,032 | $205 |
| New patient visit (30+ min) | 85 | $7,925 | $93 |
| Exam of ear using a microscope | 150 | $5,284 | $28 |
| Diagnostic exam of voice box using a flexible endoscope | 46 | $5,082 | $108 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 13 | $2,705 | $193 |
| New patient visit (60+ min) | 13 | $2,424 | $186 |
| Long return visit (40+ min) | 13 | $1,895 | $135 |
| Removal of impacted ear wax | 50 | $1,720 | $34 |
| Exam of the nose and throat using an endoscope | 16 | $1,582 | $99 |
| Test for abnormal eye movement using 3 positions with recording | 49 | $1,222 | $23 |
| Repositioning exercises of head for treatment of dizziness, each day | 18 | $715 | $38 |
2016: 11 services
| Short return visit (20+ min) | 409 | $38,962 | $62 |
| Return visit (30+ min) | 129 | $13,833 | $94 |
| New patient visit (45+ min) | 73 | $10,204 | $140 |
| Diagnostic exam of nasal passages using an endoscope | 36 | $8,965 | $199 |
| Exam of ear using a microscope | 174 | $5,881 | $28 |
| New patient visit (30+ min) | 58 | $4,982 | $86 |
| Diagnostic exam of voice box using a flexible endoscope | 43 | $4,652 | $101 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 12 | $3,034 | $217 |
| Test for abnormal eye movement using 3 positions with recording | 59 | $1,712 | $24 |
| Repositioning exercises of head for treatment of dizziness, each day | 27 | $1,080 | $35 |
| Removal of impacted ear wax | 17 | $840 | $47 |
2015: 9 services
| Short return visit (20+ min) | 435 | $44,930 | $63 |
| Diagnostic exam of nasal passages using an endoscope | 45 | $14,797 | $206 |
| New patient visit (30+ min) | 111 | $9,782 | $88 |
| Return visit (30+ min) | 79 | $9,007 | $89 |
| New patient visit (45+ min) | 53 | $7,446 | $140 |
| Exam of ear using a microscope | 185 | $6,343 | $27 |
| Diagnostic exam of voice box using a flexible endoscope | 37 | $3,913 | $106 |
| Test for abnormal eye movement using 3 positions with recording | 81 | $2,449 | $23 |
| Repositioning exercises of head for treatment of dizziness, each day | 28 | $1,490 | $38 |
2014: 10 services
| Short return visit (20+ min) | 392 | $43,299 | $63 |
| Diagnostic exam of nasal passages using an endoscope | 61 | $17,119 | $195 |
| New patient visit (45+ min) | 110 | $14,980 | $136 |
| New patient visit (30+ min) | 138 | $12,366 | $90 |
| Return visit (30+ min) | 86 | $8,512 | $81 |
| Exam of ear using a microscope | 177 | $6,158 | $27 |
| Diagnostic exam of voice box using a flexible endoscope | 39 | $4,015 | $98 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 14 | $2,932 | $195 |
| Test for abnormal eye movement using 3 positions with recording | 73 | $2,016 | $23 |
| Repositioning exercises of head for treatment of dizziness, each day | 25 | $1,344 | $38 |
2013: 13 services
| Short return visit (20+ min) | 266 | $25,747 | $62 |
| New patient visit (45+ min) | 110 | $15,845 | $144 |
| Return visit (30+ min) | 117 | $12,874 | $93 |
| Diagnostic exam of nasal passages using an endoscope | 35 | $9,850 | $205 |
| Exam of ear using a microscope | 117 | $4,101 | $30 |
| New patient visit (30+ min) | 36 | $3,214 | $89 |
| New patient visit (60+ min) | 18 | $3,200 | $178 |
| Diagnostic exam of voice box using a flexible endoscope | 26 | $2,827 | $105 |
| Repositioning exercises of head for treatment of dizziness, each day | 23 | $1,064 | $37 |
| Test for abnormal eye movement using 3 positions with recording | 33 | $903 | $24 |
| Comprehensive hearing and speech recognition test | 43 | $894 | $21 |
| Removal of impacted ear wax | 17 | $718 | $42 |
| Test for eardrum and muscle function | 37 | $426 | $12 |
Medicaid work
$41 in 2024
Medicaid paid $41 for 26 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Comprehensive audiometry threshold evaluation and speech recognition | 14 | $35 |
| Tympanometry and reflex threshold measurements | 12 | $6 |
| 2024 | 26 | 2 | 14 | $41 |
| 2023 | 24 | 2 | 12 | $39 |
See the largest Medicaid services in earlier years
2023
| Comprehensive audiometry threshold evaluation and speech recognition | 12 | $33 |
| Tympanometry and reflex threshold measurements | 12 | $6 |
Drugs they prescribed that Part D paid
$9,006
Pharmacies billed $9,006 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
383 generic and 24 brand-name prescriptions · $9,006 in drug cost · 74 antibiotic prescriptions to 65 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciprofloxacin-Dexamethasone | 12 | $1,213 | $101 |
| Ofloxacin | 24 | $767 | $32 |
| Clotrimazole | 20 | $614 | $31 |
| Clarithromycin | 14 | $598 | $43 |
| Cefdinir | 18 | $588 | $33 |
See all 17 drugs
| Ciprofloxacin-Dexamethasone | 12 | $1,213 | $101 |
| Ofloxacin | 24 | $767 | $32 |
| Clotrimazole | 20 | $614 | $31 |
| Clarithromycin | 14 | $598 | $43 |
| Cefdinir | 18 | $588 | $33 |
| Ciprofloxacin | 31 | $473 | $15 |
| Clotrimazole-Betamethasone | 36 | $439 | $12 |
| Vitamin D2 | 17 | $385 | $23 |
| Mometasone Furoate | 11 | $285 | $26 |
| Nortriptyline | 14 | $246 | $18 |
| Ondansetron Odt | 12 | $243 | $20 |
| Fluconazole | 13 | $146 | $11 |
| Amoxicillin-Clavulanate Potass | 19 | $139 | $7 |
| Methylprednisolone | 15 | $111 | $7 |
| Ibuprofen | 21 | $104 | $5 |
| Prednisone | 19 | $90 | $5 |
| Fluticasone Propionate | 11 | $60 | $5 |
Year by year
| 2024 | 407 | 197 | None | 6% | $9,006 |
| 2023 | 405 | 201 | None | 7% | $12,977 |
| 2022 | 406 | 194 | None | 9% | $14,952 |
| 2021 | 375 | 183 | None | 6% | $12,583 |
| 2020 | 336 | 159 | None | 4% | $11,553 |
| 2019 | 305 | 169 | 4% (13) | 7% | $15,101 |
| 2018 | 310 | 150 | 4% (12) | 12% | $13,605 |
| 2017 | 315 | 147 | None | 8% | $17,047 |
| 2016 | 357 | 150 | None | 12% | $18,926 |
| 2015 | 381 | 169 | 5% (17) | 15% | $23,262 |
| 2014 | 488 | 179 | 4% (20) | 28% | $34,850 |
| 2013 | 448 | 166 | 3% (15) | 33% | $35,997 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Ciprofloxacin-Dexamethasone | 13 | $1,655 | $127 |
| Nortriptyline | 28 | $917 | $33 |
| Ofloxacin | 11 | $889 | $81 |
| Clotrimazole-Betamethasone | 35 | $815 | $23 |
| Cefuroxime | 19 | $635 | $33 |
| Mometasone Furoate | 13 | $437 | $34 |
| Clotrimazole | 14 | $367 | $26 |
| Amoxicillin-Clavulanate Potass | 19 | $351 | $18 |
| Ciprofloxacin | 21 | $284 | $14 |
| Triamterene-Hydrochlorothiazid | 26 | $253 | $10 |
| Ondansetron Odt | 15 | $202 | $13 |
| Prednisone | 29 | $155 | $5 |
| Ibuprofen | 15 | $135 | $9 |
| Vitamin D2 | 16 | $118 | $7 |
2022: 15 drugs
| Ciprofloxacin-Dexamethasone | 11 | $2,051 | $186 |
| Cefuroxime | 17 | $1,142 | $67 |
| Mometasone Furoate | 24 | $1,076 | $45 |
| Clotrimazole-Betamethasone | 51 | $916 | $18 |
| Ciprofloxacin | 34 | $621 | $18 |
| Clotrimazole | 12 | $557 | $46 |
| Nortriptyline | 21 | $349 | $17 |
| Amoxicillin-Clavulanate Potass | 15 | $316 | $21 |
| Ondansetron Odt | 11 | $273 | $25 |
| Clindamycin | 14 | $199 | $14 |
| Fluticasone Propionate | 11 | $160 | $15 |
| Vitamin D2 | 12 | $137 | $11 |
| Triamterene-Hydrochlorothiazid | 13 | $112 | $9 |
| Prednisone | 19 | $95 | $5 |
| Ibuprofen | 12 | $59 | $5 |
2021: 12 drugs
| Ciprofloxacin-Dexamethasone | 12 | $2,496 | $208 |
| Clotrimazole | 18 | $786 | $44 |
| Cefuroxime | 13 | $525 | $40 |
| Ciprofloxacin | 27 | $467 | $17 |
| Clarithromycin | 11 | $426 | $39 |
| Clotrimazole-Betamethasone | 38 | $414 | $11 |
| Mometasone Furoate | 16 | $375 | $23 |
| Triamterene-Hydrochlorothiazid | 23 | $279 | $12 |
| Amoxicillin-Clavulanate Potass | 15 | $239 | $16 |
| Nortriptyline | 16 | $214 | $13 |
| Prednisone | 20 | $111 | $6 |
| Ibuprofen | 15 | $78 | $5 |
2020: 10 drugs
| Clarithromycin | 13 | $684 | $53 |
| Clotrimazole | 12 | $560 | $47 |
| Cefuroxime | 11 | $443 | $40 |
| Clotrimazole-Betamethasone | 35 | $372 | $11 |
| Ciprofloxacin | 34 | $312 | $9 |
| Amoxicillin-Clavulanate Potass | 16 | $206 | $13 |
| Fluticasone Propionate | 20 | $205 | $10 |
| Mupirocin | 15 | $146 | $10 |
| Prednisone | 21 | $124 | $6 |
| Ibuprofen | 14 | $73 | $5 |
2019: 10 drugs
| Tobramycin-Dexamethasone | 12 | $1,771 | $148 |
| Ofloxacin | 25 | $1,727 | $69 |
| Clarithromycin | 19 | $896 | $47 |
| Ipratropium | 12 | $460 | $38 |
| Cefuroxime | 13 | $458 | $35 |
| Clotrimazole-Betamethasone | 21 | $281 | $13 |
| Amoxicillin-Clavulanate Potass | 25 | $260 | $10 |
| Prednisone | 31 | $183 | $6 |
| Hydrocodone-Acetaminophen | 13 | $59 | $5 |
| Ibuprofen | 12 | $54 | $4 |
2018: 11 drugs
| Ciprodex | 17 | $3,733 | $220 |
| Azelastine | 16 | $1,248 | $78 |
| Cefuroxime | 21 | $961 | $46 |
| Maxidex | 11 | $819 | $74 |
| Clarithromycin | 15 | $646 | $43 |
| Clotrimazole | 11 | $528 | $48 |
| Fluticasone Propionate | 26 | $273 | $11 |
| Prednisone | 31 | $196 | $6 |
| Clotrimazole-Betamethasone | 12 | $156 | $13 |
| Amoxicillin-Clavulanate Potass | 15 | $115 | $8 |
| Hydrocodone-Acetaminophen | 11 | $47 | $4 |
2017: 10 drugs
| Ciprodex | 12 | $2,433 | $203 |
| Ofloxacin | 16 | $2,212 | $138 |
| Azelastine | 21 | $1,748 | $83 |
| Clarithromycin | 16 | $707 | $44 |
| Cefuroxime | 17 | $699 | $41 |
| Fluticasone Propionate | 30 | $398 | $13 |
| Triamterene-Hydrochlorothiazid | 14 | $304 | $22 |
| Prednisone | 20 | $192 | $10 |
| Verapamil | 11 | $160 | $15 |
| Nortriptyline | 14 | $128 | $9 |
2016: 11 drugs
| Ciprodex | 12 | $2,315 | $193 |
| Azelastine | 21 | $1,927 | $92 |
| Cefuroxime | 14 | $931 | $67 |
| Cefdinir | 16 | $644 | $40 |
| Omeprazole | 18 | $361 | $20 |
| Fluticasone Propionate | 38 | $329 | $9 |
| Verapamil Er | 12 | $261 | $22 |
| Triamterene-Hydrochlorothiazid | 14 | $203 | $14 |
| Mupirocin | 14 | $188 | $13 |
| Amoxicillin-Clavulanate Potass | 11 | $136 | $12 |
| Prednisone | 15 | $119 | $8 |
2015: 10 drugs
| Nasonex | 20 | $4,943 | $247 |
| Ciprodex | 13 | $2,282 | $176 |
| Cefdinir | 30 | $1,514 | $50 |
| Ofloxacin | 11 | $494 | $45 |
| Fluticasone Propionate | 36 | $380 | $11 |
| Prednisone | 26 | $219 | $8 |
| Triamterene-Hydrochlorothiazid | 19 | $190 | $10 |
| Amoxicillin-Clavulanate Potass | 11 | $188 | $17 |
| Mupirocin | 13 | $170 | $13 |
| Hydrocodone-Acetaminophen | 16 | $132 | $8 |
2014: 16 drugs
| Nasonex | 33 | $6,363 | $193 |
| Ciprodex | 19 | $3,009 | $158 |
| Patanase | 11 | $2,166 | $197 |
| Cefdinir | 37 | $2,143 | $58 |
| Clarithromycin | 20 | $1,555 | $78 |
| Azelastine | 20 | $1,317 | $66 |
| Fluticasone Propionate | 50 | $861 | $17 |
| Cefuroxime | 16 | $571 | $36 |
| Ofloxacin | 14 | $315 | $22 |
| Ketorolac Tromethamine | 12 | $291 | $24 |
| Clotrimazole-Betamethasone | 12 | $276 | $23 |
| Triamterene-Hydrochlorothiazid | 12 | $222 | $18 |
| Hydrocodone-Acetaminophen | 20 | $151 | $8 |
| Clotrimazole | 13 | $134 | $10 |
| Prednisone | 20 | $131 | $7 |
| Ibuprofen | 17 | $105 | $6 |
2013: 12 drugs
| Nasonex | 38 | $6,188 | $163 |
| Patanase | 25 | $5,470 | $219 |
| Cefdinir | 28 | $1,727 | $62 |
| Clarithromycin | 16 | $1,465 | $92 |
| Fluocinolone Acetonide Oil | 11 | $865 | $79 |
| Fluticasone Propionate | 19 | $505 | $27 |
| Ofloxacin | 21 | $371 | $18 |
| Mupirocin | 17 | $225 | $13 |
| Clotrimazole | 11 | $159 | $14 |
| Hydrocodone-Acetaminophen | 15 | $138 | $9 |
| Prednisone | 26 | $109 | $4 |
| Ibuprofen | 16 | $89 | $6 |
Money from drug and device companies
$190 in 2025
| 2025 | 2 | 3 | None | $190 |
| 2024 | 3 | 3 | None | $246 |
| 2023 | 1 | 1 | None | $25 |
| 2022 | 1 | 1 | None | $14 |
| 2021 | 2 | 2 | None | $127 |
| 2019 | 3 | 6 | None | $439 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 3 published payments
| Pfizer | Meals · 2025-08-28 | Nurtec Odt | $125 |
| Medtronic | Meals · 2025-04-05 | Midas Rex | $30 |
| Medtronic | Meals · 2025-04-05 | Midas Rex | $35 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $246
| Neurent Medical | Neuromark Device | $201 | 1 payment
|
| Cochlear Americas | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $23 | 1 payment
|
| Optinose US | Xhance | $22 | 1 payment
|
2023: $25
| Optinose US | Xhance | $25 | 1 payment
|
2022: $14
| GlaxoSmithKline | Nucala | $14 | 1 payment
|
2021: $127
| Intersect ENT | Sinuva | $101 | 1 payment
|
| Stryker | Xpress Ent Dilation System | $26 | 1 payment
|
2019: $439
| Med-El | Vibrant Soundbridge Middle Ear Implant and Bonebridge System | $270 | 2 payments
|
| Genzyme | Dupixent | $122 | 1 payment
|
| Aerin Medical | Vivaer Rf Stylus | $47 | 1 payment
|
Professional record
- NPI
- 1336169259
- Licence
- CA G48506California G48506: Current · expires 2028-05-31
- Trained
- Creighton University School of Medicine, 1981
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207YX0901X (207YX0901X); Otolaryngology (207Y00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-21
- NPI last updated
- 2024-05-14
- NPI record certified
- 2024-05-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 14981 National Ave Ste 5, Los Gatos, CA, 95032